selenium has been researched along with paclitaxel in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Deng, H; Liu, J; Xu, M; Xu, T; Zheng, W | 1 |
| Buckley, B; Caffrey, PB; Frenkel, GD; Gibbon, DG; Gounder, M; Hellmann, M; Kane, MP; Kumaran, MN; Nieves-Neira, W; Rodriguez-Rodriguez, L; Shih, W; Song, M; Vaidya, A | 1 |
| Chen, P; Chen, Q; Guo, M; He, Z; Kan, Q; Luo, C; Sun, B; Sun, J; Sun, M; Wang, M; Wang, Y; Yang, W; Yu, H; Zhang, H; Zhang, X; Zuo, S | 1 |
| Cen, W; Chen, Z; Huang, D; Liang, F; Su, S; Xia, Y; Zeng, Y; Zhang, X; Zou, J | 1 |
| Kim, HS; Lee, M; Lee, N; Lee, S; Paik, H; Park, SJ; Yim, GW | 1 |
| Basavegowda, N; Chaitanyakumar, A; Isaq, M; Jayakodi, S; Menon, S; Shanmugam, VK; Somu, P; Yadav, KK | 1 |
2 trial(s) available for selenium and paclitaxel
| Article | Year |
|---|---|
Phase I trial of selenium plus chemotherapy in gynecologic cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Chemotherapy-Induced Febrile Neutropenia; DNA-Binding Proteins; Down-Regulation; Female; Gene Expression; Glutathione Peroxidase; Humans; Infections; Lung Diseases; Maximum Tolerated Dose; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Response Evaluation Criteria in Solid Tumors; RNA-Binding Proteins; Selenious Acid; Selenium; Selenoprotein P | 2018 |
Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind
Topics: Administration, Intravenous; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase III as Topic; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Pharmaceutical Preparations; Platinum; Quality of Life; Randomized Controlled Trials as Topic; Selenium | 2021 |
4 other study(ies) available for selenium and paclitaxel
| Article | Year |
|---|---|
Se/Ru-Decorated Porous Metal-Organic Framework Nanoparticles for The Delivery of Pooled siRNAs to Reversing Multidrug Resistance in Taxol-Resistant Breast Cancer Cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Metal-Organic Frameworks; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Phosphatidylinositol 3-Kinases; RNA, Small Interfering; Ruthenium; Selenium | 2017 |
Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbon; Cell Line, Tumor; Disulfides; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Male; Mice; Mice, Inbred BALB C; Molecular Dynamics Simulation; Nanomedicine; Nanoparticles; Oxidation-Reduction; Paclitaxel; Prodrugs; Rats; Rats, Sprague-Dawley; Selenium; Sulfur; Tumor Microenvironment | 2019 |
Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Drug Carriers; Drug Liberation; Humans; Hyaluronic Acid; Lung Neoplasms; Mice; Nanoparticles; Neoplasm Invasiveness; Paclitaxel; Selenium; Xenograft Model Antitumor Assays | 2019 |
Preparation of Paclitaxel-Encapsulated Bio-Functionalized Selenium Nanoparticles and Evaluation of Their Efficacy against Cervical Cancer.
Topics: Cell Line, Tumor; Chitosan; Female; Humans; Nanoparticles; Paclitaxel; Selenium; Uterine Cervical Neoplasms | 2022 |